Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

Amgen OncologyAmgen Oncology
VS
GenentechGenentech
Amgen Oncology

Amgen Oncology

Thousand Oaks, US

Last Update: 19/02/2026

View Profile
Between 750 and 799
http://www.amgenoncology.com
764/1000Fair

At Amgen, we are committed to the relentless pursuit of breakthroughs for cancer patients and their families. We have a deep and diverse pipeline of cutting-edge therapeutic approaches that aim to improve outcomes. Amgen has been pursuing novel treatment approaches for...

NAICS:541714
NAICS Definition:Research and Development in Biotechnology (except Nanobiotechnology)
Employees:None
Subsidiaries:4
12-month incidents
0
Known data breaches
0
Attack type number
0
Genentech

Genentech

1 Dna Way, South San Francisco, California, US, 94080

Last Update: 01/04/2026

View Profile
Between 750 and 799
http://www.gene.com
794/1000Fair

About Genentech We're passionate about finding solutions for people facing the world's most difficult-to-treat conditions. That is why we use cutting-edge science to create and deliver innovative medicines around the globe. To us, science is personal. Making a differe...

NAICS:541714
NAICS Definition:Research and Development in Biotechnology (except Nanobiotechnology)
Employees:18,082
Subsidiaries:50
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
Amgen Oncology

Amgen Oncology

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Genentech

Genentech

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Amgen Oncology in 2026.

Incidents

Incidents vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Genentech in 2026.

Incidents

Incident History - Amgen Oncology (X = Date, Y = Severity)

Amgen Oncology cyber incidents detection timeline including parent company and subsidiaries.

R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Genentech (X = Date, Y = Severity)

Genentech cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
Amgen Oncology

Amgen Oncology

Incidents
No explicit notable incidents reported.
Genentech

Genentech

Incidents
No explicit notable incidents reported.

FAQ

Between Amgen Oncology company and Genentech company, which one has the best AI Cybersecurity Score ?
Between Amgen Oncology company and Genentech company, which one has experienced more cyber incidents in the past ?
Between Amgen Oncology company and Genentech company, which one has experienced more cyber incidents this year ?
Between Amgen Oncology company and Genentech company, which one has experienced at least one ransomware attack ?
Between Amgen Oncology company and Genentech company, which one has experienced at least one data breach ?
Between Amgen Oncology company and Genentech company, which one has experienced at least one targeted cyberattack ?
Between Amgen Oncology company and Genentech company, which one has experienced at least one vulnerability ?
Between Amgen Oncology company and Genentech company, which one holds the most compliance certifications ?
Between Amgen Oncology company and Genentech company, which one holds the fewest compliance certifications ?
Between Amgen Oncology company and Genentech company, which one has the most subsidiaries ?
Between Amgen Oncology company and Genentech company, which one has the largest number of employees ?
Between Amgen Oncology and Genentech, which company holds both SOC 2 Type 1 certifications ?
Between Amgen Oncology and Genentech, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - Amgen Oncology or Genentech ?
Which company is PCI DSS compliant - Amgen Oncology or Genentech ?
Between Amgen Oncology and Genentech, which company complies with HIPAA regulations for healthcare data ?
Between Amgen Oncology and Genentech, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-56078
SUMMARY

PraisonAI before 1.5.115 contains a path traversal vulnerability in MultiAgentMonitor that fails to sanitize agent IDs when building file paths. Attackers can include traversal sequences like ../ in agent IDs to read, write, or overwrite arbitrary files, enabling sensitive disclosure, denial of service, or code execution.

PUBLISHED
Date2026-06-18
UPDATED
Date2026-06-18
RISK INFORMATION (Score: 8.8)
CVSS3
Base Score: 8.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
CVSS4
Base Score: 8.7
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
5.9
EXPLOITABILITY
2.8
CVE-2026-56077
SUMMARY

PraisonAI before 1.5.115 contains an information disclosure vulnerability in the MultiAgentLedger component that allows attackers to access sensitive data by registering agents with duplicate IDs. Attackers can exploit the lack of agent ID uniqueness enforcement to share ledger instances and expose system prompts and conversation history between agents.

PUBLISHED
Date2026-06-18
UPDATED
Date2026-06-18
RISK INFORMATION (Score: 6.5)
CVSS3
Base Score: 6.5
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N
CVSS4
Base Score: 7.1
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:N/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.6
EXPLOITABILITY
2.8
CVE-2026-56076
SUMMARY

PraisonAI before 1.5.128 contains a cross-origin agent execution vulnerability in the AGUI endpoint that allows remote attackers to trigger arbitrary agent execution. The POST /agui endpoint lacks authentication and hardcodes Access-Control-Allow-Origin: * headers, combined with Starlette's Content-Type-agnostic JSON parsing, enabling attackers to bypass CORS preflight checks via simple requests and exfiltrate sensitive agent responses including tool execution results and environment data.

PUBLISHED
Date2026-06-18
UPDATED
Date2026-06-18
RISK INFORMATION (Score: 8.1)
CVSS3
Base Score: 8.1
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:N
CVSS4
Base Score: 8.6
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:H/VI:H/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
5.2
EXPLOITABILITY
2.8
CVE-2026-56075
SUMMARY

PraisonAI before 4.5.128 contains an arbitrary shell command execution vulnerability where the UI modules hardcode approval_mode to auto, overriding administrator configuration from PRAISON_APPROVAL_MODE environment variable. Authenticated attackers can instruct the LLM agent to execute arbitrary shell commands via subprocess.run with shell=True, bypassing the manual approval gate and insufficient command sanitization blocklists.

PUBLISHED
Date2026-06-18
UPDATED
Date2026-06-18
RISK INFORMATION (Score: 8.8)
CVSS3
Base Score: 8.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
CVSS4
Base Score: 8.7
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
5.9
EXPLOITABILITY
2.8
CVE-2026-56074
SUMMARY

PraisonAI before 1.5.128 caches tool approval decisions by tool name only, not by invocation arguments, allowing subsequent execute_command calls to bypass approval prompts. Attackers can exploit this by obtaining initial approval for a benign command, then silently exfiltrate API keys and credentials via subsequent shell commands without user consent.

PUBLISHED
Date2026-06-18
UPDATED
Date2026-06-18
RISK INFORMATION (Score: 5.5)
CVSS3
Base Score: 5.5
Complexity: LOW
CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:H/I:N/A:N
CVSS4
Base Score: 6.8
Complexity: LOW
CVSS:4.0/AV:L/AC:L/AT:N/PR:N/UI:P/VC:H/VI:N/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.6
EXPLOITABILITY
1.8